|
Tuesday, December 1, 2009
|
|
17:30 - 19:30
|
Welcome Reception - Hosted by TJAB
Meet with speakers and other attendees at this informal reception
|
Focus Lounge, 1st Floor, Holiday Inn Binhai Tianjin
|
|
Day 1 - Wednesday, December 2, 2009
|
|
Time
|
Title/Description
|
Speakers
|
|
08:00 - 09:00
|
Registration and Refreshments
|
|
|
09:00 - 09:30
|
Welcome Remarks
|
Greg Scott - CEO & Founder, ChinaBio® LLC
|
|
Yu Zhao, PhD - Vice President, Tianjin International Joint Academy of Biotechnology and Medicine (TJAB)
|
|
09:30 - 10:00
|
Keynote 1: Biomedical Innovation in Tianjin
With the opening of the Tianjin International Joint Academy of Biotechnology and Medicine (TJAB), Tianjin is rapidly becoming a leading source of bio-medical innovation in China. By providing a variety of support, TJAB has already attracted nearly 50 R&D projects in the areas of drugs, vaccines, diagnostics and medical instruments.
|
Zihe Rao - President, Tianjin International Joint Academy of Biotechnology and Medicine (TJAB)
|
|
10:00 - 10:30
|
Keynote 2: The State of China's Biotech Industry
China's life science industry is moving quickly from services to innovation. Hear the latest update on novel technology development, investment, M&A and partnering deals, and other data from ChinaBio's research team.
|
Greg Scott - CEO & Founder, ChinaBio® LLC
|
|
10:30 - 11:00
|
Networking Break and Refreshments
|
|
|
11:00 - 12:00
|
Panel 1: Global Success Stories
China's biomedical companies now understand that to be successful they must address the global market, not just China. Hear successful entrepreneurs and their investors tell how they built their businesses from startup to a global enterprise.
|
Moderator: Bo Wen, MBA - Managing Director, The Balloch Group
|
|
Panelists:
|
| Peng Cheng, PhD - Senior Director, Chemistry Department, WuXi Apptec |
|
Hao Hong, PhD - Chairman and CEO, Asymchem Laboratories Inc.
|
|
Dan Zhang, MD, MPH - Chairman and CEO, Fountain Medical Development Ltd.
|
|
12:00 - 13:30
|
Luncheon
|
|
|
13:30 - 14:30
|
Panel 2: Navigating Regulatory Approvals in China and the US
Nearly all biomedical companies must face the hurdle of gaining regulatory approval for their products before they can take them to market. This can be a long and expensive process. Regulatory experts with FDA and SFDA experience discuss how the process can be shortened, and the odds for success can be improved.
|
Moderator: Changchun Yuan, JD - Partner, Broad & Bright
|
|
Panelists:
|
|
John Z. Gong, PhD, MD - VP and CTO, Managing Director, US Operations, JOINN Laboratories
|
|
Ning Li, MD, PhD - Senior Group Regulatory and Medical Policy Director, Sanofi-Aventis China
|
|
Maria Song, PhD, MD - President, VPS-CRO Group
|
|
Dan Zhang, MD, MPH - Chairman and CEO, Fountain Medical Development Ltd.
|
|
14:30 - 17:00
|
Company Presentations
|
8-10 Companies (Two Tracks)
|
|
17:00 - 18:00
|
TJAB Tour / Shuttle Bus to Banquet
|
|
|
18:00 - 20:00
|
Gala Banquet
|
Xi Ying Ying Seafood Restaurant
|
|
Day 2 - Thursday, December 3, 2009
|
|
Time
|
Title/Description
|
Speakers
|
|
08:00 - 09:00
|
Registration and Refreshments
|
|
|
09:00 - 09:30
|
Special Guest Speaker
|
Vivian Li, Deputy General Manager, TEDA Venture Capital Co., Ltd.
|
|
09:30 - 10:30
|
Panel 3: Partnering Opportunities in China
Partnering has become a new method for companies to attract funding to progress their development efforts. There is a variety of partnering opportunities including in/out-licensing, co-development, project collaborations, etc. Executives a variety of companies discuss how to partner with them and what to expect in support and funding.
|
Moderator: Timothy Wong, PhD - Market Development Manager, Drug Discovery, Pharma and CRO, Asia Pacific, Invitrogen / Life Technologies
|
|
Panelists:
|
|
R. Stephen Porter, PharmD - CSO, Medicilon/MPI Preclinical Research
|
|
Pu Wang - Co-CEO, Head of China Office, Xin Tech (Bio Sciences) Ltd.
|
|
Ian Wisenberg - SVP, Strategic Development, ChinaBio® LLC
|
|
Nathan Zhang, MD, PhD, MBA - Founder & CEO, Sinocro Medicals
|
|
10:30 - 11:00
|
Break and Refreshments
|
|
|
11:00 - 12:00
|
Panel 4: Fund Raising B10in Changing Times
The funding environment is improving, but raising funds for an early stage life science company is still a challenge. Hear from active VC investors what a company must do to attract their interest - and cash.
|
Moderator: David Xu, PhD, MBA - Managing Partner, Mingly China Growth Fund
|
|
Panelists:
|
|
Walter Lau, PhD - Vice President, Fidelity Asia Ventures
|
|
Wayne Li, PhD - General Project Manager, Morningside
|
|
Chuck Ng - Managing Director, Hambrecht Suma Capital
|
|
Marc A. Schueler, MD, PhD, MBA - Director Venturing, DSM
|
|
12:00 - 13:30
|
Luncheon
|
|
|
13:30 - 16:00
|
Company Presentations
|
8-10 Companies (Two Tracks)
|
|
16:00 - 16:30
|
Raffle Drawings - Win valuable prizes
|
|
|
16:30 - 17:00
|
Award Ceremony / Closing Remarks
|
|
